Erratum: Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic 
Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency 
Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial.